The Department of Health and Human Services (HHS) has released a market research report for the IVIS Spectrum CT Revvity Signature Service Plan. Authored by William Lonergan, this report details the need for a maintenance contract for an IVIS spectrophotometer, now unsupported by its previous contractor, REMI. The objective is compliant with federal acquisition regulations, focusing on ensuring equipment reliability and adherence to regulatory guidelines like CLIA and QMS.
The main interest lies in securing Revvity, a capable vendor formed from the acquisition of PerkinElmer's division. Revvity is positioned as the sole qualified provider for maintenance services, given their expertise and infrastructure, including 11,000 employees and a global presence. The report assesses market capabilities, confirming Revvity's competitive pricing and reliability. It concludes with recommendations for engaging Revvity for the maintenance contract to ensure continuous operational efficiency and compliance with safety procedures. This report aligns with the government's procurement goals, emphasizing effective vendor selection for critical biomedical laboratory services.
The document outlines the justification for a sole source procurement by the Centers for Disease Control and Prevention (CDC) for the maintenance plan of the IVIS Spectrum CT instrument. It highlights that only Revvity Health Sciences, Inc. can service this proprietary equipment without voiding its warranty and emphasizes the necessity of this decision in maintaining compatibility and continuity of operations. The justification is in accordance with FAR regulations, specifying that only one source is available due to factors such as proprietary data and compatibility issues. Efforts to identify other potential service providers were unsuccessful, reaffirming the sole vendor choice. The document includes certifications from both the Program Office and the Contracting Office, confirming the accuracy and need for this non-competitive procurement.